-
Something wrong with this record ?
Enzymatic synthesis of dimeric glycomimetic ligands of NK cell activation receptors
A. Drozdová, P. Bojarová, K. Křenek, L. Weignerová, B. Henssen, L. Elling, H. Christensen, HH. Jensen, H. Pelantová, M. Kuzma, K. Bezouška, M. Krupová, D. Adámek, K. Slámová, V. Křen,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Lymphocyte Activation drug effects immunology MeSH
- beta-N-Acetylhexosaminidases metabolism MeSH
- Biomimetics methods MeSH
- Killer Cells, Natural chemistry drug effects immunology metabolism MeSH
- Antigens, CD immunology metabolism MeSH
- Antigens, Differentiation, T-Lymphocyte immunology metabolism MeSH
- Galactosyltransferases genetics metabolism MeSH
- Immunoprecipitation MeSH
- Rats MeSH
- Lectins, C-Type agonists immunology metabolism MeSH
- Humans MeSH
- Ligands MeSH
- Molecular Mimicry MeSH
- Mutation MeSH
- Placenta enzymology MeSH
- Polysaccharides chemical synthesis pharmacology MeSH
- Receptors, Natural Killer Cell agonists immunology metabolism MeSH
- Recombinant Proteins genetics metabolism MeSH
- Pregnancy MeSH
- Protein Binding drug effects immunology MeSH
- Binding Sites drug effects immunology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
This work reveals new structural relationships in the complex process of the interaction between activation receptors of natural killer cells (rat NKR-P1, human CD69) and novel bivalent carbohydrate glycomimetics. The length, glycosylation pattern and linker structure of receptor ligands were examined with respect to their ability to precipitate the receptor protein from solution, which simulates the in vivo process of receptor aggregation during NK cell activation. It was found that di-LacdiNAc triazole compounds show optimal performance, reaching up to 100% precipitation of the present protein receptors, and achieving high immunostimulatory activities without any tendency to trigger activation-induced apoptosis. In the synthesis of the compounds tested, two enzymatic approaches were applied. Whereas a β-N-acetylhexosaminidase could only glycosylate one of the two acceptor sites available with yields below 10%, the Y284L mutant of human placental β1,4-galactosyltransferase-1 worked as a perfect synthetic tool, accomplishing even quantitative glycosylation at both acceptor sites and with absolute regioselectivity for the C-4 position. This work insinuates new directions for further ligand structure optimisation and demonstrates the strong synthetic potential of the mutant human placental β1,4-galactosyltransferase-1 in the synthesis of multivalent glycomimetics and glycomaterials.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028279
- 003
- CZ-PrNML
- 005
- 20121206123444.0
- 007
- ta
- 008
- 120817e20110503ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.carres.2011.04.043 $2 doi
- 035 __
- $a (PubMed)21641586
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Drozdová, Anna $u Institute of Microbiology, Academy of Sciences of Czech Republic, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic.
- 245 10
- $a Enzymatic synthesis of dimeric glycomimetic ligands of NK cell activation receptors / $c A. Drozdová, P. Bojarová, K. Křenek, L. Weignerová, B. Henssen, L. Elling, H. Christensen, HH. Jensen, H. Pelantová, M. Kuzma, K. Bezouška, M. Krupová, D. Adámek, K. Slámová, V. Křen,
- 520 9_
- $a This work reveals new structural relationships in the complex process of the interaction between activation receptors of natural killer cells (rat NKR-P1, human CD69) and novel bivalent carbohydrate glycomimetics. The length, glycosylation pattern and linker structure of receptor ligands were examined with respect to their ability to precipitate the receptor protein from solution, which simulates the in vivo process of receptor aggregation during NK cell activation. It was found that di-LacdiNAc triazole compounds show optimal performance, reaching up to 100% precipitation of the present protein receptors, and achieving high immunostimulatory activities without any tendency to trigger activation-induced apoptosis. In the synthesis of the compounds tested, two enzymatic approaches were applied. Whereas a β-N-acetylhexosaminidase could only glycosylate one of the two acceptor sites available with yields below 10%, the Y284L mutant of human placental β1,4-galactosyltransferase-1 worked as a perfect synthetic tool, accomplishing even quantitative glycosylation at both acceptor sites and with absolute regioselectivity for the C-4 position. This work insinuates new directions for further ligand structure optimisation and demonstrates the strong synthetic potential of the mutant human placental β1,4-galactosyltransferase-1 in the synthesis of multivalent glycomimetics and glycomaterials.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a CD antigeny $x imunologie $x metabolismus $7 D015703
- 650 _2
- $a diferenciační antigeny T-lymfocytů $x imunologie $x metabolismus $7 D000945
- 650 _2
- $a vazebná místa $x účinky léků $x imunologie $7 D001665
- 650 _2
- $a biomimetika $x metody $7 D032701
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a galaktosyltransferasy $x genetika $x metabolismus $7 D005700
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoprecipitace $7 D047468
- 650 _2
- $a buňky NK $x chemie $x účinky léků $x imunologie $x metabolismus $7 D007694
- 650 _2
- $a lektiny typu C $x agonisté $x imunologie $x metabolismus $7 D037181
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a aktivace lymfocytů $x účinky léků $x imunologie $7 D008213
- 650 _2
- $a molekulární mimikry $7 D018716
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a placenta $x enzymologie $7 D010920
- 650 _2
- $a polysacharidy $x chemická syntéza $x farmakologie $7 D011134
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a vazba proteinů $x účinky léků $x imunologie $7 D011485
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a receptory buněk NK $x agonisté $x imunologie $x metabolismus $7 D055607
- 650 _2
- $a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
- 650 _2
- $a beta-N-acetylhexosaminidasy $x metabolismus $7 D001619
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bojarová, Pavla
- 700 1_
- $a Křenek, Karel
- 700 1_
- $a Weignerová, Lenka
- 700 1_
- $a Henssen, Birgit
- 700 1_
- $a Elling, Lothar
- 700 1_
- $a Christensen, Helle
- 700 1_
- $a Jensen, Henrik H
- 700 1_
- $a Pelantová, Helena
- 700 1_
- $a Kuzma, Marek
- 700 1_
- $a Bezouška, Karel
- 700 1_
- $a Krupová, Monika
- 700 1_
- $a Adámek, David $7 gn_A_00001276
- 700 1_
- $a Slámová, Kristýna
- 700 1_
- $a Křen, Vladimír
- 773 0_
- $w MED00001049 $t Carbohydrate research $x 1873-426X $g Roč. 346, č. 12 (20110503), s. 1599-609
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21641586 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121206123518 $b ABA008
- 999 __
- $a ok $b bmc $g 950321 $s 785625
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 346 $c 12 $d 1599-609 $e 20110503 $i 1873-426X $m Carbohydrate research $n Carbohydr Res $x MED00001049
- LZP __
- $a Pubmed-20120817/11/04